Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000019064
Abstract: Supplemental Digital Content is available in the text read more here.
Keywords: efficacy safety; bivalirudin heparin; coronary heart; patients coronary ... See more keywords
Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15251
Abstract: Unfractionated heparin (UFH) has been the primary anticoagulant of choice on extracorporeal membrane oxygenation (ECMO). However, it is debatable whether bivalirudin (BIV), a direct thrombin inhibitor, may be considered a better alternative anticoagulant option. read more here.
Keywords: membrane oxygenation; extracorporeal membrane; bivalirudin heparin;